Physician profile
Diana E Rosenberg
NPI 1861488009
$2,733.80
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,013 · 2020: $600 · 2021: $833 · 2022: $225 · 2023: $41.55 · 2024: $21.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $63.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $63.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $809.94 | 2019-2022 | |
| Lilly USA, LLC | $358.36 | 2019-2022 | |
| Amgen INC. | $204.52 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $203.51 | 2019-2022 | |
| Glaxosmithkline, LLC. | $156.99 | 2019-2022 | |
| Pfizer INC. | $156.05 | 2019-2020 | |
| Gilead Sciences, INC. | $131.97 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $118.63 | 2019-2022 | |
| Esperion Therapeutics, INC. | $107.17 | 2021 | |
| Janssen Pharmaceuticals, INC | $83.29 | 2020-2022 | |
| Novo Nordisk INC | $75.97 | 2019 | |
| Shire North American Group INC | $72.53 | 2019 | |
| Abbvie INC. | $70.48 | 2022-2024 | Ubrelvy |
| Neos Therapeutics, Lp | $33.17 | 2019 | |
| Cranial Technologies, INC | $31.78 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $27.21 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $23.14 | 2020 | |
| Amarin Pharma, INC. | $21.75 | 2021 | |
| Genentech USA, INC. | $21.67 | 2019 | |
| Ethicon INC. | $13.26 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.